News and Events

Introduction4-(4-Methylpiperazinylmethyl)benzoyl chloride DiHCl (CAS No. 106261-64-7) is a highly significant and strategic organic compound. It serves as a crucial, highly activated pharmaceutical intermediate in the late-stage synthesis of a high-value, clinically important API used in modern onco

Introduction4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride (CAS No. 106261-49-8) is a highly significant and strategic organic compound. It serves as a crucial pharmaceutical intermediate in the synthesis of a high-value, clinically important API used in modern oncology. The compound

IntroductionN-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine (CAS No. 152460-10-1) is a highly significant and strategic organic compound. It serves as a crucial pharmaceutical intermediate in the late-stage synthesis of a high-value, clinically important API used in modern oncology. This

IntroductionN-(5-nitro-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine (CAS No. 152460-09-8) is a highly significant and strategic organic compound. It serves as a crucial pharmaceutical intermediate in the synthesis of a high-value, clinically important API used in modern oncology. This compound is

Introduction3-(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one (CAS No. 55314-16-4) is a highly significant and strategic organic compound. It serves as a crucial pharmaceutical intermediate in the synthesis of a variety of high-value APIs. The compound is a versatile enaminone, a functional group th

Introduction3-Pyridylacetic acid hydrochloride (CAS No. 6419-36-9) is a highly significant and strategic organic compound. It serves as a crucial pharmaceutical intermediate in the synthesis of a high-value class of bisphosphonate APIs, such as Risedronic acid. The presence of a key pyridine ring an

IntroductionRisedronic acid (CAS No. 105462-24-6) is a well-established and clinically significant active pharmaceutical ingredient (API). It belongs to the class of drugs known as bisphosphonates, which are widely prescribed for the treatment and prevention of osteoporosis, a condition characterize

Introduction5-Methyl-4-isoxazolecarboxylic acid (CAS No. 42831-50-5) is a highly significant and strategic organic compound. It serves as a crucial pharmaceutical intermediate in the synthesis of a high-value class of antibacterial agents. The presence of a key isoxazole ring and a carboxylic acid f

Introduction(R)-5-(Azidomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone (CAS No. 168828-84-0) is a highly significant and strategic organic compound. It serves as a crucial pharmaceutical intermediate in the synthesis of a high-value class of antibacterial agents. The presence of a key

Introduction(R)-N-(3-(-Fluoro-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl) methanol mesylate (CAS No. 174649-09-3) is a highly significant and strategic organic compound. It serves as a crucial pharmaceutical intermediate in the synthesis of a high-value class of antibacterial agents. This compound